Activated protein C resistance during in vitro fertilization treatment

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 95, Issue 2, 2001, Pages 222-224

  Curvers, J ^a   Nienhuis, S J ^b   Nap, A W ^b   Hamulyak K ^b   Evers, J L H ^b   Rosing, J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

APC resistance; Estrogens; IVF treatment; Oral contraceptives; Venous thrombosis

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; BLOOD CLOTTING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HEMOSTASIS; HUMAN; PREGNANCY; PRIORITY JOURNAL; RISK; VEIN THROMBOSIS;

EID: 0035047770     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00495-4     Document Type: Conference Paper

References (32)

1. Venous thromboembolism during pregnancy
2. Risk of venous thrombosis with hormone-replacement therapy
3. Risk of venous thromboembolism in users of hormone replacement therapy
4. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progestin replacement study
5. Oral contraceptives and cardiovascular disease (first of two parts)
6. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
7. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational research group on oral contraceptives and the health of young women
8. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing third-generation progestagen
9. Coagulation effects of oral contraception
10. Effects of oral contraceptives on haemostasis variables
11. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review
12. APC resistance and other haemostatic variables during pregnancy and puerperium
13. Thrombosis in pregnancy: maternal and fetal issues
14. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy
15. Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice
16. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay
17. Influence of hormone replacement therapy, oral contraceptives and pregnancy on APC resistance
18. Resistance to activated protein C in healthy women taking oral contraceptives
19. Sensitivity to activated protein C: influence of oral contraceptives and sex
20. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives
21. End of the line for third-generation-pill controversy?
22. Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation
23. Effects of oral contraceptives on hemostasis and thrombosis
24. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques
25. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports
26. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism
27. Hyperestrogenism induced by menotropins alone or in conjunction with luprolide acetate in in vitro fertilization cycles: the impact on hemostasis
28. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation?
29. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals
30. Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization - embryo transfer treatment: a comparison between conception and non-conception cycles
31. APC resistance determined with the endogenous thrombin potential is associated with venous thrombosis: a blinded clinical evaluation